Literature DB >> 15553237

Screening of the interaction between xenobiotic transporters and PDZ proteins.

Yukio Kato1, Kazuhiro Yoshida, Chizuru Watanabe, Yoshimichi Sai, Akira Tsuji.   

Abstract

PURPOSE: Xenobiotic transporters have been proposed to be involved in membrane penetration of various therapeutic agents. As little information is available on molecular mechanism of their functional regulation, we have attempted to clarify the protein-protein interactions of such transporters as a first step to identify their regulators.
METHODS: Yeast two-hybrid screening was performed to examine the interaction between carboxylic terminus of various xenobiotic transporters and PDZ (PSD95, D1g and ZO1) domain-containing proteins. The interaction and functional regulation were also evaluated in pull-down, immunoprecipitation and transport studies.
RESULTS: Specific interaction with PDZ proteins was identified for several xenobiotic transporters including PEPT1, PEPT2, OCT3, OCTN1, OCTN2, OAT4, OATP-A, OATP-D, and OATP-F. The potent interaction was observed between PEPT2 and PDZK1, and deletion of the last four amino acids of the PEPT2 C-terminus almost completely abrogated such interaction. Recombinant PEPT2 C-terminus fusion protein can bind to purified His6-tagged PDZK1, confirming the involvement of two of four PDZ domains within PDZK1 in the interaction. Alanine-scanning mutation in PEPT2 revealed the presence of a consensus sequence (-T-X-L) that is responsible for the PDZK1 interaction. Transfection of PDZK1 increased the uptake of glycylsarcosine by PEPT2, whereas such stimulation was not observed for PEPT2 with the last four amino acids deleted.
CONCLUSIONS: These results first identified the interaction between PDZ proteins and the cytosolic tail of various xenobiotic transporters. PDZK1 directly interacts with PEPT2, exerting functional regulation of its transporting activity. The current findings imply the localization of PEPT2 within a protein network constructed from PDZK1 and other transporter proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15553237     DOI: 10.1023/b:pham.0000045244.83999.43

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  41 in total

1.  PDZ-domain interactions and apical expression of type IIa Na/P(i) cotransporters.

Authors:  Nati Hernando; Nadine Déliot; Serge M Gisler; Eleanor Lederer; Edward J Weinman; Jürg Biber; Heini Murer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

Review 2.  Transporters and xenobiotic disposition.

Authors:  Richard B Kim
Journal:  Toxicology       Date:  2002-12-27       Impact factor: 4.221

Review 3.  Signaling complex organization by PDZ domain proteins.

Authors:  Jing-Song Fan; Mingjie Zhang
Journal:  Neurosignals       Date:  2002 Nov-Dec

4.  Transporter-mediated Drug Interactions.

Authors:  Akira Tsuji
Journal:  Drug Metab Pharmacokinet       Date:  2002       Impact factor: 3.614

5.  cAMP-mediated inhibition of the epithelial brush border Na+/H+ exchanger, NHE3, requires an associated regulatory protein.

Authors:  C H Yun; S Oh; M Zizak; D Steplock; S Tsao; C M Tse; E J Weinman; M Donowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

6.  A kinase-regulated mechanism controls CFTR channel gating by disrupting bivalent PDZ domain interactions.

Authors:  Viswanathan Raghuram; Hayley Hormuth; J Kevin Foskett
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-24       Impact factor: 11.205

7.  Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.

Authors:  I Tamai; R Ohashi; J Nezu; H Yabuuchi; A Oku; M Shimane; Y Sai; A Tsuji
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

8.  Targeted disruption of the peptide transporter Pept2 gene in mice defines its physiological role in the kidney.

Authors:  Isabel Rubio-Aliaga; Isabelle Frey; Michael Boll; David A Groneberg; Hans M Eichinger; Rudi Balling; Hannelore Daniel
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

Review 9.  Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions.

Authors:  C U Nielsen; B Brodin
Journal:  Curr Drug Targets       Date:  2003-07       Impact factor: 3.465

10.  Regulation of cystic fibrosis transmembrane conductance regulator single-channel gating by bivalent PDZ-domain-mediated interaction.

Authors:  V Raghuram; D O Mak; J K Foskett
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

View more
  16 in total

Review 1.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 3.  Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 Proteins.

Authors:  Dustin R Walsh; Thomas D Nolin; Peter A Friedman
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

Review 4.  Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease.

Authors:  Michael Murray; Fanfan Zhou
Journal:  Br J Pharmacol       Date:  2017-04-24       Impact factor: 8.739

Review 5.  Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion-transporting polypeptides.

Authors:  Wooin Lee; Jeong-Min Ha; Yuichi Sugiyama
Journal:  J Biol Chem       Date:  2020-10-13       Impact factor: 5.157

Review 6.  Transcriptional and functional regulation of the intestinal peptide transporter PEPT1.

Authors:  Britta Spanier
Journal:  J Physiol       Date:  2013-08-19       Impact factor: 5.182

Review 7.  Organic anion-transporting polypeptides.

Authors:  Bruno Stieger; Bruno Hagenbuch
Journal:  Curr Top Membr       Date:  2014       Impact factor: 3.049

Review 8.  Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications.

Authors:  David E Smith; Benjamin Clémençon; Matthias A Hediger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

Review 9.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

Review 10.  Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.

Authors:  Hermann Koepsell; Katrin Lips; Christopher Volk
Journal:  Pharm Res       Date:  2007-05-01       Impact factor: 4.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.